cAMP sensor Epac as a determinant of ATP‐sensitive potassium channel activity in human pancreatic β cells and rat INS‐1 cells
- 7 June 2006
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 573 (3), 595-609
- https://doi.org/10.1113/jphysiol.2006.107391
Abstract
The Epac family of cAMP-regulated guanine nucleotide exchange factors (cAMPGEFs, also known as Epac1 and Epac2) mediate stimulatory actions of the second messenger cAMP on insulin secretion from pancreatic beta cells. Because Epac2 is reported to interact in vitro with the isolated nucleotide-binding fold-1 (NBF-1) of the beta-cell sulphonylurea receptor-1 (SUR1), we hypothesized that cAMP might act via Epac1 and/or Epac2 to inhibit beta-cell ATP-sensitive K+ channels (K(ATP) channels; a hetero-octomer of SUR1 and Kir6.2). If so, Epac-mediated inhibition of K(ATP) channels might explain prior reports that cAMP-elevating agents promote beta-cell depolarization, Ca2+ influx and insulin secretion. Here we report that Epac-selective cAMP analogues (2'-O-Me-cAMP; 8-pCPT-2'-O-Me-cAMP; 8-pMeOPT-2'-O-Me-cAMP), but not a cGMP analogue (2'-O-Me-cGMP), inhibit the function of K(ATP) channels in human beta cells and rat INS-1 insulin-secreting cells. Inhibition of K(ATP) channels is also observed when cAMP, itself, is administered intracellularly, whereas no such effect is observed upon administration N6-Bnz-cAMP, a cAMP analogue that activates protein kinase A (PKA) but not Epac. The inhibitory actions of Epac-selective cAMP analogues at K(ATP) channels are mimicked by a cAMP agonist (8-Bromoadenosine-3', 5'-cyclic monophosphorothioate, Sp-isomer, Sp-8-Br-cAMPS), but not a cAMP antagonist (8-Bromoadenosine-3', 5'-cyclic monophosphorothioate, Rp-isomer, Rp-8-Br-cAMPS), and are abrogated following transfection of INS-1 cells with a dominant-negative Epac1 that fails to bind cAMP. Because both Epac1 and Epac2 coimmunoprecipitate with full-length SUR1 in HEK cell lysates, such findings delineate a novel mechanism of second messenger signal transduction in which cAMP acts via Epac to modulate ion channel function, an effect measurable as the inhibition of K(ATP) channel activity in pancreatic beta cells.Keywords
This publication has 77 references indexed in Scilit:
- Calcium-induced Acrosomal Exocytosis Requires cAMP Acting through a Protein Kinase A-independent, Epac-mediated PathwayJournal of Biological Chemistry, 2006
- Cyclic AMP/cAMP‐GEF pathway amplifies insulin exocytosis induced by Ca2+ and ATP in rat islet β‐cellsDiabetes/Metabolism Research and Reviews, 2005
- Ligand-mediated Activation of the cAMP-responsive Guanine Nucleotide Exchange Factor EpacJournal of Biological Chemistry, 2003
- Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the β2-adrenergic receptorThe Journal of cell biology, 2003
- Structure and regulation of the cAMP-binding domains of Epac2Nature Structural & Molecular Biology, 2002
- Involvement of Calmodulin in Glucagon‐Like Peptide 1(7‐36) Amide‐Induced Inhibition of the ATP‐Sensitive K+ Channel in Mouse Pancreatic β‐CellsExperimental Physiology, 2001
- Expression of cAMP-Regulated Guanine Nucleotide Exchange Factors in Pancreatic β-CellsBiochemical and Biophysical Research Communications, 2000
- PIP 2 and PIP as Determinants for ATP Inhibition of K ATP ChannelsScience, 1998
- Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea ReceptorScience, 1995
- Pharmacology of Protein Kinase InhibitorsAnnual Review of Pharmacology and Toxicology, 1992